Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Scientists and doctors consider the question being asked by LENS important because it could improve treatment for people who have diabetes by reducing the risk which retinopathy poses to vision. Scientists at the University of Oxford are co-ordinating the study with the collaboration of the Universities of Glasgow, Aberdeen, Edinburgh and Dundee, and with doctors and nurses from around Scotland. The trial design has been reviewed and agreed by the West of Scotland Research Ethics Committee whose duty it is to check whether the health question being asked is important enough to warrant a trial, and that the trial is being carried out in an independent, honest and professional manner.

An independent committee oversees the study and monitors the results. This committee could stop the trial early if important new evidence emerged that had an impact on the need for the trial to continue.

Thank you for your interest in this trial. Our aim is to make your participation an interesting and worthwhile experience, while helping us and others to improve the treatment of people who have diabetic retinopathy. If you have any further questions that have not been addressed within this section, please contact us:

  • 24-hour Freephone: 0808 164 5090